Navigation Links
Actos Diabetes Medication Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP

New York, New York (PRWEB) July 23, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging that Actos caused a New York man to develop bladder cancer. The suit was filed on July 15, 2013, in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-2242). It is one of thousands of cases filed as part of the multidistrict litigation (MDL) entitled In Re: Actos (pioglitazone) Products Liability Litigation (6:11-md-2299). Takeda Pharmaceuticals, America; Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc.; Takeda Pharmaceutical Company Limited; and Eli Lilly and Company have been named as Defendants. Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiffs’ Steering Committee in the litigation.

According to the Complaint, the Plaintiff took Actos from about October 2005 to February 2011, which is when the Plaintiff started to suffer from bladder cancer, allegedly due to Actos. The U.S. Food and Drug Administration(FDA) has warned about the risks of taking Actos. On June 15, 2011, the agency said that taking Actos for more than a year could significantly increase the risk of bladder cancer. The safety label on Actos was updated to address this risk.

Some research studies provide additional support for the notion of a link between Actos and bladder cancer. The British Medical Journal published a study on May 31, 2012, that revealed Actos users were twice as likely to develop bladder cancer after two years. Then, on July 3, 2012, the Canadian Medical Association Journal reported that patients taking the medication were 22 percent more likely to get bladder cancer.

Parker Waichman LLP continues to offer free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Actos Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Actos Bladder Cancer Litigation
2. Texas Man Suffering from Bladder Cancer Because of Actos Use, Alleges Lawsuit Filed by Parker Waichman LLP
3. Actos Bladder Cancer Lawsuit News: Bernstein Liebhard LLP Comments on India Regulatory Agency Decision to Ban Actos
4. Actos Caused Bladder Cancer and Wrongful Death of New York Woman, Alleges Lawsuit Filed by Parker Waichman LLP
5. Florida Man Develops Bladder Cancer as Result of Taking Actos, Alleges Lawsuit Filed by Parker Waichman LLP
6. Actos Lawsuits Move Forward, as Bernstein Liebhard LLP Reports on Recent Status Conference in Federal Actos Bladder Cancer Litigation
7. Actos Lawsuit News: Plaintiff Claims Actos Causes Bladder Cancer, Rottenstein Law Group LLP Reports
8. Lawsuit Alleging Actos Caused Arizona Man’s Bladder Cancer Filed by Parker Waichman LLP
9. Buckfire & Buckfire, P.C. Dangerous Drug Lawyers Now Accepting Michigan Actos Lawsuits
10. Actos Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Actos Bladder Cancer Litigation
11. Parker Waichman LLP Represents Pennsylvania Man in Lawsuit Alleging Actos Caused his Bladder Cancer
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... TransPack Volume 6 features 30 customizable transitions ... scrolling web-styled transitions to wipes with blur & drop shadow options. Utilize the ... transition from one clip to the next with TransPack's easily customizable styles. ...
(Date:11/30/2015)... ... November 30, 2015 , ... Innovaacom, a leading ... results of a survey of educational needs for pharmacists worldwide. The poll of ... demand for high quality online and face-to-face education for pharmacists who are fast ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... partnership at the Radiological Society of North America (RSNA) 2015 conference. , ... cutting-edge dictation and speech-enabled documentation software, announced their partnership today at RSNA ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... 2016. In 2016, expected coding changes are likely to include new codes for ... It’s not easy to understand the effects of code changes in musculoskeletal, radiology ...
(Date:11/30/2015)... ... ... announced the introduction of three Nightstick® brand LED traffic wands with an average retail price ... ), yellow ( NSP-1634 ) and blue ( NSP-1636 ), the SL-1600 series LED traffic ... blinking strobe mode using a fresh set of 3 AAA cells (included). , Built to ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Royal Philips (NYSE: PHG AEX: PHIA) ... user interface and automatic scan parameter selection to help ... such as knee and hip replacements, spine implants and ... America Annual Meeting (RSNA) . The new software helps ... growing patient population. ScanWise Implant adds to Philips, suite ...
(Date:11/30/2015)... and BOCA RATON, Fla. , Nov. ... Commercialization of Public Research (the Institute) announced today ... KynderMed , a medical device start-up company with technology ... company creation based on publicly-funded research, and bridges early ... Florida -based universities and research institutions. ...
(Date:11/30/2015)... , Nov. 30, 2015 ... global biopharmaceutical leader dedicated to delivering transformative ... underserved medical conditions, today announced the launch ... (Recombinant), PEGylated], an extended circulating half-life recombinant ... based on full-length ADVATE [Antihemophilic Factor (Recombinant)]. ...
Breaking Medicine Technology: